U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"What can be more palpably absurd than the prospect held out of locomotives traveling twice as fast as stagecoaches?"

The Quarterly Review ; March edition, 1825

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Examiner: Chism, B. Dell


Primary examiner statistics: 55 patents; average approval time: 55 days
Assistant examiner statistics: 54 patents; average approval time: 1383 days

Patents as Primary Examiner (view all)

Patent No. Patent Title:
7335643 Compositions of active Wnt protein
7335500 Production of fucosylated carbohydrates by enzymatic fucosylation...
7332475 Preventive or therapeutic composition for viral infectious diseas...
7268118 Thymosin β4 compositions
7262164 Polymeric thiol-linked prodrugs employing benzyl elimination syst...
7262169 Process for preparing peptide intermediates
7259143 Method of extending the dose range of vitamin D compounds
7247701 Amino amides, peptides and peptidomimetics
7244710 Treatment of ophthalmic infections using antimicrobial peptides
7232879 Glucagon-like insulinotropic peptides, compositions and methods
7232804 Use of KPV tripeptide for dermatological disorders
7230073 Sperm specific proteins
7226910 Treatment of female sexual dysfunction with vasoactive intestinal...
7217688 Methods and compositions for derepression of IAP-inhibited caspas...
7217545 Method for production of lactic acid
7214659 Reduction of the electrocardiographic QT interval
7214664 Peptidyl prodrugs that resist P-glycoprotein mediated drug efflux
7208138 Contrast enhancement agent for magnetic resonance imaging
7205277 Zinc-free and low-zinc insulin preparations having improved stabi...
7205276 Zinc-free and low-zinc insulin preparations having improved stabi...
7202218 Oligopeptide antagonist of interleukin-6
7196063 Peptides and pharmaceutical compositions comprising same
7192931 Treatment of demyelinating diseases
7189701 Tetrapeptide stimulating functional activity of neurons pharmacol...
7186687 Compositions and methods for treatment of Psoriasis
7183255 Method for stabilizing blood pressure in hemodialysis subjects
7179789 Compositions and methods for treatment of rosacea
7173009 Surfactant protein C esters
7169750 Methods to mobilize progenitor/stem cells
7166594 Streptogramin derivatives, their preparation and compositions con...
7166579 Prodrugs of DP IV-inhibitors
7166706 Use of ketol-acid reductoisomerase inhibitors to prevent or treat...
7163671 Long-term stabilized formulations
7160857 Methods for increasing schwann cell survival
7160853 Protocol for paracentesis
7160984 Process for preparing glycopeptide derivatives
7153832 Compositions of active Wnt protein
7148195 LHRH antagonists having improved solubility properties
7148191 Antigenic composition
7144857 Vancomycin haemostatic paste composition

Patents as Assistant Examiner (view all)

Patent No. Patent Title:
7192713 Stabilized compounds having secondary structure motifs
7166296 Pharmaceutical formulations and ligands for use therein; mimetics...
7109160 Peptides containing the motif IGD and their use as cell migration...
7101854 Tetrapeptide stimulating the functional activity of hepatocytes, ...
7094753 Somatostatin analog and uses thereof
7094548 Purification of recombinant proteins fused to multiple epitopes
7091184 Hepatitis C inhibitor tri-peptides
7078378 Method of tissue repair II
7070969 Plasmin inhibitors from the australian brown snake
7067486 Acetylcholinesterase-derived peptides and uses thereof
7041462 Conformational and topological protein regulation
7030213 Conformationally stabilized cell adhesion peptides
7022671 Surfactant protein C esters
7015305 Process for preparing glycopeptide derivatives
7015021 Method for making purified plasminogen activator-inhibitor type 1...
7008925 Melanocortin 1 receptor selective compounds
7005419 Methods for identifying inhibitors of GADD45 polypeptide activity...
6979673 Method and compositions for modulating somatolactogenic functions
6979672 Cyclosporin-based pharmaceutical compositions
6977242 Two gonadotropin releasing hormones and a method to isolate the s...
6972122 Contrast enhancement agent for magnetic resonance imaging
6967192 Seventeen amino acid peptide (Peptide P) for treating ischemia an...
6960561 Zinc-free and low-zinc insulin preparations having improved stabi...
6956027 N-terminally chemically modified protein compositions and methods
6927205 Compositions and methods for treatment of psoriasis
6927206 Compositions and methods for treatment of rosacea
6906171 Process for the deprotection of protected thiols
6902720 Cyclic peptide structures for molecular scale electronic and phot...
6894028 Use of KPV tripeptide for dermatological disorders
6887476 Method for treating pain with botulinum toxin type B
6884771 Angiotensin converting enzyme homolog and uses therefor
6872704 Acidic mammalian proteins and polynucleotides encoding the same
6869934 Method of purifying calcium ion-binding protein
6867184 Methods of treating diabetic cardiomyopathy using glycogen phosph...
6867291 Human hemicentin proteins and polynucleotides encoding the same
6864232 Agent for treating visual cell function disorder
6858114 Laser hydrolysis of polypeptides
6852694 Stabilized insulin formulations
6835378 Method and compositions for inhibiting thrombin-induced coagulati...
6833353 Use of immunosuppressants for MMP mediated diseases
 
Sign InRegister
Username  
Password   
forgot password?